Arizona State Retirement System’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-902
Closed -$201K 2226
2022
Q2
$201K Buy
902
+3
+0.3% +$1K ﹤0.01% 1934
2022
Q1
$494K Buy
899
+10
+1% +$6.04K ﹤0.01% 1478
2021
Q4
$588K Sell
889
-7
-0.8% -$5.35K ﹤0.01% 1435
2021
Q3
$752K Buy
896
+33
+4% +$33.5K 0.01% 1279
2021
Q2
$1.1M Sell
863
-62
-7% -$70K 0.01% 1045
2021
Q1
$1.01M Buy
925
+213
+30% +$281K 0.01% 1100
2020
Q4
$1.02M Sell
712
-20
-3% -$21.3K 0.01% 1037
2020
Q3
$517K Buy
732
+210
+40% +$153K 0.01% 1287
2020
Q2
$366K Buy
+522
New +$301K 0.01% 1293

Other funds holding CDLX

Arizona State Retirement System's CDLX Position: Q3 2022 in Review

Arizona State Retirement System sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 902 shares — an estimated $201K sold.

Arizona State Retirement System first reported a position in CDLX in Q2 2020 and held it in 9 quarters. The position peaked at $1.1M in Q2 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Arizona State Retirement System reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Arizona State Retirement System sold 902 Cardlytics shares in Q3 2022, an estimated $201K.
  • Arizona State Retirement System first reported a position in Cardlytics in Q2 2020 and held it in 9 quarters.
  • Arizona State Retirement System's Cardlytics position peaked at $1.1M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Arizona State Retirement System's 13F filing for Q3 2022, filed 7 Nov 2022.